Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2025
About
Suggestions
Contact Us
Salmeterol Xinafoate
MeSH Descriptor Data 2024
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Salmeterol Xinafoate
Tree Number(s)
D02.033.100.291.057.750
D02.092.063.291.057.750
D02.092.471.683.061.750
Unique ID
D000068299
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068299
Scope Note
A selective ADRENERGIC BETA-2 RECEPTOR agonist that functions as a
BRONCHODILATOR
when administered by inhalation. It is used to manage the symptoms of
ASTHMA
and
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
.
Entry Term(s)
Salmeterol
Serevent
Pharm Action
Bronchodilator Agents
Adrenergic beta-2 Receptor Agonists
Related Numbers
2I4BC502BT
Public MeSH Note
2016; SALMETEROL XINAFOATE was indexed under ALBUTEROL 1989-2015
History Note
2016 (1989)
Date Established
2016/01/01
Date of Entry
2015/07/01
Revision Date
2015/06/05
Allowable Qualifiers
administration & dosage (AD)
adverse effects (AE)
agonists (AG)
analogs & derivatives (AA)
analysis (AN)
antagonists & inhibitors (AI)
blood (BL)
cerebrospinal fluid (CF)
chemical synthesis (CS)
chemistry (CH)
classification (CL)
economics (EC)
history (HI)
immunology (IM)
isolation & purification (IP)
metabolism (ME)
pharmacokinetics (PK)
pharmacology (PD)
poisoning (PO)
radiation effects (RE)
standards (ST)
supply & distribution (SD)
therapeutic use (TU)
toxicity (TO)
urine (UR)
Organic Chemicals [D02]
Alcohols [D02.033]
Amino Alcohols [D02.033.100]
Ethanolamines [D02.033.100.291]
Albuterol [D02.033.100.291.057]
Albuterol, Ipratropium Drug Combination [D02.033.100.291.057.125]
Levalbuterol [D02.033.100.291.057.500]
Salmeterol Xinafoate [D02.033.100.291.057.750]
Fluticasone-Salmeterol Drug Combination [D02.033.100.291.057.750.500]
Organic Chemicals [D02]
Amines [D02.092]
Amino Alcohols [D02.092.063]
Ethanolamines [D02.092.063.291]
Albuterol [D02.092.063.291.057]
Albuterol, Ipratropium Drug Combination [D02.092.063.291.057.125]
Levalbuterol [D02.092.063.291.057.500]
Salmeterol Xinafoate [D02.092.063.291.057.750]
Fluticasone-Salmeterol Drug Combination [D02.092.063.291.057.750.500]
Organic Chemicals [D02]
Amines [D02.092]
Ethylamines [D02.092.471]
Phenethylamines [D02.092.471.683]
Albuterol [D02.092.471.683.061]
Albuterol, Ipratropium Drug Combination [D02.092.471.683.061.125]
Levalbuterol [D02.092.471.683.061.500]
Salmeterol Xinafoate [D02.092.471.683.061.750]
Fluticasone-Salmeterol Drug Combination [D02.092.471.683.061.750.500]
Expand All
Collapse All
Salmeterol Xinafoate
Preferred
Concept UI
M000602359
Related Numbers
2I4BC502BT
Scope Note
A selective ADRENERGIC BETA-2 RECEPTOR agonist that functions as a
BRONCHODILATOR
when administered by inhalation. It is used to manage the symptoms of
ASTHMA
and
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
.
Terms
Salmeterol Xinafoate
Preferred Term
Term UI
T000875119
Date
02/11/2015
LexicalTag
NON
ThesaurusID
Serevent
Narrower
Concept UI
M000603335
Terms
Serevent
Preferred Term
Term UI
T191615
Date
01/01/1955
LexicalTag
TRD
ThesaurusID
NLM (1989)
Salmeterol
Broader
Concept UI
M000603386
Terms
Salmeterol
Preferred Term
Term UI
T000875121
Date
02/11/2015
LexicalTag
NON
ThesaurusID
page delivered in 0.141s